LMAT

103.55

1.49% 1.525

Handel nachbörslich: 103.55 0.005 +0.00%

Lemaitre Vascular Inc (LMAT)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Dividendenhistorie

Schlusskurs vom Vortag:

$102.02

Offen:

$101.93

24-Stunden-Volumen:

94,754

Relative Volume:

0.85

Marktkapitalisierung:

$2.34B

Einnahmen:

$205.62M

Nettoeinkommen (Verlust:

$37.68M

KGV:

85.57

EPS:

1.21

Netto-Cashflow:

$31.69M

1W Leistung:

-1.85%

1M Leistung:

+15.20%

6M Leistung:

+31.99%

1J Leistung:

+94.96%

1-Tages-Spanne:

$101.75

$104.61

1-Wochen-Bereich:

$100.45

$106.11

52-Wochen-Spanne:

$51.70

$106.49

Lemaitre Vascular Inc Stock (LMAT) Company Profile

Firmenname

Lemaitre Vascular Inc

Sektor

Healthcare (1196)

Branche

Medical Instruments & Supplies (58)

Telefon

781-221-2266

Adresse

63 SECOND AVENUE, BURLINGTON, MA

Mitarbeiter

630

Twitter

@LMAT_Vascular

Nächster Verdiensttermin

2024-10-31

Neueste SEC-Einreichungen

LMAT's Discussions on Twitter

Vergleichen Sie LMAT mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
LMAT	103.55	2.34B	205.62M	37.68M	31.69M	1.21
ISRG	531.64	190.09B	7.87B	2.24B	586.00M	4.25
BDX	224.10	65.14B	20.18B	1.73B	3.07B	5.51
ALC	85.81	42.44B	9.76B	1.16B	665.00M	0.72
RMD	239.42	34.99B	4.81B	1.11B	1.35B	6.16
WST	307.21	22.29B	2.88B	499.60M	321.60M	7.41

Lemaitre Vascular Inc Stock (LMAT) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-02-06	Fortgesetzt	KeyBanc Capital Markets	Sector Weight
2023-10-23	Eingeleitet	JMP Securities	Mkt Outperform
2023-09-06	Eingeleitet	Oppenheimer	Outperform
2023-08-03	Herabstufung	Jefferies	Buy → Hold
2023-05-03	Hochstufung	Barrington Research	Mkt Perform → Outperform
2022-10-28	Herabstufung	Barrington Research	Outperform → Mkt Perform
2021-09-16	Eingeleitet	Jefferies	Buy
2021-02-12	Eingeleitet	KeyBanc Capital Markets	Sector Weight
2020-03-16	Hochstufung	Sidoti	Neutral → Buy
2019-10-24	Herabstufung	First Analysis Sec	Strong Buy → Outperform
2019-10-24	Hochstufung	Lake Street	Hold → Buy
2019-10-14	Hochstufung	First Analysis Sec	Outperform → Strong Buy
2019-07-25	Bestätigt	Barrington Research	Outperform
2019-07-25	Hochstufung	First Analysis Sec	Neutral → Outperform
2018-10-08	Hochstufung	Barrington Research	Mkt Perform → Outperform
2018-10-08	Hochstufung	ROTH Capital	Neutral → Buy
2018-06-08	Fortgesetzt	ROTH Capital	Buy
2018-04-26	Herabstufung	Stifel	Buy → Hold
2018-04-26	Hochstufung	The Benchmark Company	Hold → Buy
2017-10-27	Herabstufung	First Analysis Sec	Overweight → Equal-Weight
2017-10-27	Herabstufung	The Benchmark Company	Buy → Hold
2017-07-10	Herabstufung	Canaccord Genuity	Buy → Hold
2017-07-10	Herabstufung	The Benchmark Company	Buy → Hold
2017-03-21	Eingeleitet	First Analysis Sec	Overweight
2017-02-22	Herabstufung	Barrington Research	Outperform → Mkt Perform
2016-09-22	Herabstufung	Sidoti	Buy → Neutral
2016-07-28	Bestätigt	Barrington Research	Outperform
2016-02-25	Bestätigt	Barrington Research	Outperform

Alle ansehen

Lemaitre Vascular Inc Aktie (LMAT) Neueste Nachrichten

Nov 15, 2024

LeMaitre Vascular director Shadan Martha sells $151,547 in stock - Investing.com

Nov 15, 2024

Nov 13, 2024

(LMAT) Technical Data - Stock Traders Daily

Nov 13, 2024

LeMaitre Vascular, Inc. (NASDAQ:LMAT) Stake Raised by Los Angeles Capital Management LLC - MarketBeat

Nov 13, 2024

Nov 09, 2024

LMATLeMaitre Vascular, Inc. Latest Stock News & Market Updates - StockTitan

Nov 09, 2024

LeMaitre Vascular (NASDAQ:LMAT) Sets New 1-Year HighShould You Buy? - MarketBeat

Nov 09, 2024

Creative Planning Has $334,000 Stock Holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - Defense World

Nov 09, 2024

Portside Wealth Group LLC Takes Position in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat

Nov 09, 2024

Nov 08, 2024

LeMaitre Vascular stock soars to all-time high of $104.33 By Investing.com - Investing.com UK

Nov 08, 2024

Nov 05, 2024

LeMaitre Vascular's SWOT analysis: niche market leader's stock faces valuation scrutiny - Investing.com India

Nov 05, 2024

(01/18/21) Top Picks 2021: Avid Technology (AVID) and LeMaitre Vascular (LM - Moneyshow.com

Nov 05, 2024

Harbor Capital Advisors Inc. Buys 12,797 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat

Nov 05, 2024

Nov 04, 2024

FY2024 EPS Forecast for LeMaitre Vascular Lifted by Analyst - MarketBeat

Nov 04, 2024

Nov 03, 2024

LeMaitre Vascular: Market Catching On To Dividend Growth Story (NASDAQ:LMAT) - Seeking Alpha

Nov 03, 2024

LeMaitre Vascular, Inc. (NASDAQ:LMAT) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat

Nov 03, 2024

LeMaitre Vascular, Inc. (NASDAQ:LMAT) Receives Average Rating of “Moderate Buy” from Analysts - Defense World

Nov 03, 2024

Nov 02, 2024

LeMaitre Vascular, Inc. (NASDAQ:LMAT) Plans Quarterly Dividend of $0.16 - MarketBeat

Nov 02, 2024

LeMaitre Vascular, Inc. (NASDAQ:LMAT) Shares Bought by F M Investments LLC - MarketBeat

Nov 02, 2024

LeMaitre Vascular, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions - Simply Wall St

Nov 02, 2024

LeMaitre Vascular Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance

Nov 02, 2024

LeMaitre Vascular (NASDAQ:LMAT) Hits New 12-Month High Following Earnings Beat - Defense World

Nov 02, 2024

Nov 01, 2024